Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluating liquid biopsies for methylomic profiling of prostate cancer

31 Jan 2020

Abstract excerpt

Background: Liquid biopsies offer significant potential for informing on cancer progression and therapeutic resistance via minimally invasive serial monitoring of genetic alterations. Although the cancer epigenome is a central driving force in most neoplasia, the accuracy of monitoring the tumor methylome using liquid biopsies remains relatively unknown. Objectives: to investigate how well two types of liquid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32000564
DOI: 10.1080/15592294.2020.1712876

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluating liquid biopsies for methylomic profiling of prostate cancerPMID 32000564Read ↗

Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancerSemantic proximity Read ↗

epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate CancerSemantic proximity Read ↗

Multiparametric liquid biopsy analysis in metastatic prostate cancerSemantic proximity Read ↗

Liquid biopsy in prostate cancer: A novel dual biomarker analysis approach integrating circulating tumor cells and circulating tumor DNA data.Semantic proximity Read ↗

Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer.Semantic proximity Read ↗

Blood-based liquid biopsy in advanced prostate cancer.Semantic proximity Read ↗

DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non‐invasive detectionSemantic proximity Read ↗

Liquid biopsy: a step forward towards precision medicine in urologic malignancies.Semantic proximity Read ↗

The Landscape of Prostate Tumour MethylationSemantic proximity Read ↗

Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker PotentialSemantic proximity Read ↗

Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with <i>de novo</i> metastatic diseaseSemantic proximity Read ↗

Unlocking the potential of tumor‐derived DNA in urine for cancer detection: methodological challenges and opportunitiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.